Read the latest positive news, breakthroughs, and inspiring stories about vanderbilt university, curated daily by BrightWire.
Vanderbilt researchers developed two groundbreaking compounds that could finally reveal what causes Alzheimer's disease at a molecular level. These chemical tools offer scientists new ways to study a mysterious protein family linked to the disease affecting over seven million Americans.
Vanderbilt researchers developed two breakthrough compounds that let scientists study TAOK proteins for the first time, opening new paths to understanding and potentially treating Alzheimer's disease. More than seven million Americans with Alzheimer's now have new hope for future treatments.
Vanderbilt's undergraduate mock trial team just punched their ticket to nationals for the first time in over a decade. The A Team went 7-1 in Memphis, proving student-run programs can compete with the best.
Researchers discovered how cells naturally reorganize a key internal structure as we age, opening doors to potential treatments for age-related diseases. The breakthrough could help people live longer and healthier lives.